S&P 500   4,026.97 (+1.75%)
DOW   34,166.24 (+0.93%)
QQQ   289.90 (+3.33%)
AAPL   146.26 (+3.61%)
MSFT   249.57 (+3.84%)
META   116.67 (+6.59%)
GOOGL   99.64 (+4.67%)
AMZN   95.23 (+3.04%)
TSLA   190.34 (+5.26%)
NVDA   164.59 (+5.24%)
NIO   12.81 (+22.00%)
BABA   89.22 (+11.72%)
AMD   76.38 (+4.07%)
T   19.07 (+0.32%)
MU   56.79 (+3.03%)
CGC   3.55 (+3.80%)
F   13.84 (+0.65%)
GE   85.53 (-0.15%)
DIS   96.62 (+2.04%)
AMC   7.37 (-0.81%)
PYPL   78.94 (+1.67%)
PFE   49.56 (+0.14%)
NFLX   304.35 (+8.33%)
S&P 500   4,026.97 (+1.75%)
DOW   34,166.24 (+0.93%)
QQQ   289.90 (+3.33%)
AAPL   146.26 (+3.61%)
MSFT   249.57 (+3.84%)
META   116.67 (+6.59%)
GOOGL   99.64 (+4.67%)
AMZN   95.23 (+3.04%)
TSLA   190.34 (+5.26%)
NVDA   164.59 (+5.24%)
NIO   12.81 (+22.00%)
BABA   89.22 (+11.72%)
AMD   76.38 (+4.07%)
T   19.07 (+0.32%)
MU   56.79 (+3.03%)
CGC   3.55 (+3.80%)
F   13.84 (+0.65%)
GE   85.53 (-0.15%)
DIS   96.62 (+2.04%)
AMC   7.37 (-0.81%)
PYPL   78.94 (+1.67%)
PFE   49.56 (+0.14%)
NFLX   304.35 (+8.33%)
S&P 500   4,026.97 (+1.75%)
DOW   34,166.24 (+0.93%)
QQQ   289.90 (+3.33%)
AAPL   146.26 (+3.61%)
MSFT   249.57 (+3.84%)
META   116.67 (+6.59%)
GOOGL   99.64 (+4.67%)
AMZN   95.23 (+3.04%)
TSLA   190.34 (+5.26%)
NVDA   164.59 (+5.24%)
NIO   12.81 (+22.00%)
BABA   89.22 (+11.72%)
AMD   76.38 (+4.07%)
T   19.07 (+0.32%)
MU   56.79 (+3.03%)
CGC   3.55 (+3.80%)
F   13.84 (+0.65%)
GE   85.53 (-0.15%)
DIS   96.62 (+2.04%)
AMC   7.37 (-0.81%)
PYPL   78.94 (+1.67%)
PFE   49.56 (+0.14%)
NFLX   304.35 (+8.33%)
S&P 500   4,026.97 (+1.75%)
DOW   34,166.24 (+0.93%)
QQQ   289.90 (+3.33%)
AAPL   146.26 (+3.61%)
MSFT   249.57 (+3.84%)
META   116.67 (+6.59%)
GOOGL   99.64 (+4.67%)
AMZN   95.23 (+3.04%)
TSLA   190.34 (+5.26%)
NVDA   164.59 (+5.24%)
NIO   12.81 (+22.00%)
BABA   89.22 (+11.72%)
AMD   76.38 (+4.07%)
T   19.07 (+0.32%)
MU   56.79 (+3.03%)
CGC   3.55 (+3.80%)
F   13.84 (+0.65%)
GE   85.53 (-0.15%)
DIS   96.62 (+2.04%)
AMC   7.37 (-0.81%)
PYPL   78.94 (+1.67%)
PFE   49.56 (+0.14%)
NFLX   304.35 (+8.33%)
NASDAQ:AMEH

Apollo Medical - AMEH Stock Forecast, Price & News

$28.95
+1.12 (+4.02%)
(As of 11/30/2022 02:26 PM ET)
Add
Compare
Today's Range
$27.26
$28.95
50-Day Range
$27.83
$41.71
52-Week Range
$27.33
$100.75
Volume
3,517 shs
Average Volume
312,669 shs
Market Capitalization
$1.64 billion
P/E Ratio
20.39
Dividend Yield
N/A
Price Target
$57.00

Apollo Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
105.6% Upside
$57.00 Price Target
Short Interest
Bearish
10.57% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.70
Upright™ Environmental Score
News Sentiment
0.87mentions of Apollo Medical in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-1.67%
From $1.20 to $1.18 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.30 out of 5 stars

Medical Sector

361st out of 1,043 stocks

Management Consulting Services Industry

11th out of 17 stocks

AMEH stock logo

About Apollo Medical (NASDAQ:AMEH) Stock

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.

Receive AMEH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apollo Medical and its competitors with MarketBeat's FREE daily newsletter.

AMEH Stock News Headlines

Apollo Medical Holdings Becomes Oversold (AMEH)
Apollo Medical Holdings, Inc. Reports Second Quarter 2022 Results
See More Headlines
Receive AMEH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apollo Medical and its competitors with MarketBeat's FREE daily newsletter.

AMEH Company Calendar

Last Earnings
11/04/2021
Today
11/30/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/23/2023

Industry, Sector and Symbol

Industry
Management consulting services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AMEH
Employees
1,133
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$57.00
High Stock Price Forecast
$57.00
Low Stock Price Forecast
$57.00
Forecasted Upside/Downside
+96.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$73.86 million
Pretax Margin
5.14%

Debt

Sales & Book Value

Annual Sales
$773.91 million
Cash Flow
$1.72 per share
Book Value
$9.05 per share

Miscellaneous

Free Float
50,194,000
Market Cap
$1.64 billion
Optionable
Not Optionable
Beta
0.71

Key Executives

  • Dr. Kenneth T. Sim M.D. (Age 68)
    Exec. Chairman
    Comp: $1.09M
  • Dr. Thomas S. Lam M.D. (Age 73)
    M.P.H., Pres, Co-CEO & Director
    Comp: $1.08M
  • Mr. Brandon  SimMr. Brandon Sim (Age 28)
    Co-Chief Exec. Officer
    Comp: $1.04M
  • Dr. WaiChow Young M.D. (Age 75)
    Chief Admin. Officer
    Comp: $453.73k
  • Mr. Chan Basho
    Chief Strategy Officer & Interim CFO
  • Dr. Jeremy R. Jackson M.D.
    Chief Quality Officer
  • Mr. Neil Ahuja
    Pres of Provider Solutions
  • Yubin Park
    Chief Analytics Officer













AMEH Stock - Frequently Asked Questions

Should I buy or sell Apollo Medical stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Apollo Medical in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AMEH shares.
View AMEH analyst ratings
or view top-rated stocks.

What is Apollo Medical's stock price forecast for 2023?

3 Wall Street research analysts have issued 12 month price objectives for Apollo Medical's stock. Their AMEH share price forecasts range from $57.00 to $57.00. On average, they expect the company's share price to reach $57.00 in the next year. This suggests a possible upside of 108.9% from the stock's current price.
View analysts price targets for AMEH
or view top-rated stocks among Wall Street analysts.

How have AMEH shares performed in 2022?

Apollo Medical's stock was trading at $73.48 at the start of the year. Since then, AMEH shares have decreased by 62.9% and is now trading at $27.29.
View the best growth stocks for 2022 here
.

Are investors shorting Apollo Medical?

Apollo Medical saw a drop in short interest in November. As of November 15th, there was short interest totaling 4,030,000 shares, a drop of 8.8% from the October 31st total of 4,420,000 shares. Based on an average daily trading volume, of 272,500 shares, the short-interest ratio is presently 14.8 days. Approximately 10.6% of the shares of the stock are sold short.
View Apollo Medical's Short Interest
.

When is Apollo Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our AMEH earnings forecast
.

How were Apollo Medical's earnings last quarter?

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) announced its earnings results on Thursday, November, 4th. The company reported $0.69 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.35. The firm had revenue of $227.12 million for the quarter. Apollo Medical had a net margin of 6.26% and a trailing twelve-month return on equity of 13.49%. During the same quarter last year, the company posted $0.45 EPS.

What guidance has Apollo Medical issued on next quarter's earnings?

Apollo Medical updated its FY 2022 earnings guidance on Thursday, November, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.09 billion-$1.11 billion, compared to the consensus revenue estimate of $1.07 billion.

What is Thomas Lam's approval rating as Apollo Medical's CEO?

15 employees have rated Apollo Medical Chief Executive Officer Thomas Lam on Glassdoor.com. Thomas Lam has an approval rating of 43% among the company's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. 28.0% of employees surveyed would recommend working at Apollo Medical to a friend.

What other stocks do shareholders of Apollo Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL), SEA (SE), Mastercard (MA), NVIDIA (NVDA), Walt Disney (DIS), Lululemon Athletica (LULU), Enphase Energy (ENPH), Main Street Capital (MAIN), Block (SQ) and Exxon Mobil (XOM).

What is Apollo Medical's stock symbol?

Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."

Who are Apollo Medical's major shareholders?

Apollo Medical's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (10.84%), Vanguard Group Inc. (7.52%), State Street Corp (2.31%), Dimensional Fund Advisors LP (0.67%), Bank of New York Mellon Corp (0.64%) and Steel Peak Wealth Management LLC (0.48%). Insiders that own company stock include Adrian Vazquez, Albert Waichow Young, Brandon Sim, Eric Chin, Linda Marsh, Physicians Of Californi Allied and Thomas S Lam.
View institutional ownership trends
.

How do I buy shares of Apollo Medical?

Shares of AMEH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Apollo Medical's stock price today?

One share of AMEH stock can currently be purchased for approximately $27.29.

How much money does Apollo Medical make?

Apollo Medical (NASDAQ:AMEH) has a market capitalization of $1.55 billion and generates $773.91 million in revenue each year. The company earns $73.86 million in net income (profit) each year or $1.42 on an earnings per share basis.

How many employees does Apollo Medical have?

The company employs 1,133 workers across the globe.

How can I contact Apollo Medical?

Apollo Medical's mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The official website for the company is www.apollomed.net. The company can be reached via phone at (626) 943-6491, via email at investors@apollomed.net, or via fax at 818-839-5190.

This page (NASDAQ:AMEH) was last updated on 11/30/2022 by MarketBeat.com Staff